7-Hydroxymitragynine Tablets/Capsules, Brand review

7-Hydroxymitragynine vs Morphine: Everything You Need to Know

Posted by

Saqib

On April 16, 2025

0 comments

In the ongoing battle against pain and opioid addiction, two compounds have sparked considerable discussion: 7-Hydroxymitragynine, a naturally occurring alkaloid found in the kratom plant, and morphine, the prototypical opioid analgesic derived from the opium poppy.

Both substances interact with the body’s opioid receptors to produce pain relief, but they differ significantly in origin, potency, mechanism of action, side effects, and potential for abuse. This blog explores the key differences and similarities between 7-hydroxymitragynine and morphine, shedding light on the broader implications in medicine, addiction treatment, and regulatory policy.

🔬 Understanding the Basics

When comparing 7-Hydroxymitragynine and morphine, it’s essential to understand how each compound interacts with the body. Both are powerful opioids, but their origins, potency, and effects reveal important differences worth exploring.

What is 7-Hydroxymitragynine?

7-Hydroxymitragynine (7-OH) is a minor but highly potent alkaloid naturally present in kratom leaves. Though it exists in low concentrations (typically <0.05%), it’s largely responsible for kratom’s analgesic (pain-relieving) and opioid-like effects.

Source: Kratom plant (Southeast Asia)
Mechanism: Partial agonist at mu-opioid receptors, similar to morphine
Potency: Estimated to be 10x more potent than morphine in animal studies

What is Morphine?

Morphine is a classical opioid analgesic derived from the opium poppy. It’s used extensively in clinical settings to manage moderate to severe pain, including cancer pain and post-surgical discomfort.

Source: Natural alkaloid from Papaver somniferum
Mechanism: Full agonist at mu-opioid receptors
Potency: Considered a baseline for measuring opioid strength

Mechanism of Action

7-Hydroxymitragynine: Acts as a partial agonist at the mu-opioid receptor (MOR), exhibiting high affinity and potency. It also interacts with kappa- and delta-opioid receptors, though to a lesser extent. Studies in Frontiers have shown that 7-OH has a binding affinity for the human MOR (Ki = 47 nM), which is higher than mitragynine and comparable to morphine .
Morphine: A full agonist at the MOR, morphine has a binding affinity for the human MOR (Ki = 3.5 nM) . It also interacts with kappa- and delta-opioid receptors, contributing to its analgesic and side effects.ScienceDirect

Potency Comparison

Analgesic Potency: In animal studies, 7-OH has demonstrated greater potency than morphine. For instance, in the tail-flick and hot-plate tests, 7-OH was found to be approximately 5.7 and 4.4 times more potent than morphine, respectively . Additionally, 7-OH has been reported to be 10- to 20-fold more potent than morphine when administered orally, likely due to its higher oral bioavailability. PubMed
Binding Affinity: 7-OH exhibits a higher binding affinity for the human MOR compared to morphine, suggesting a stronger interaction with the receptor.
Bioavailability & Metabolism: Morphine is typically administered through injection or in slow-release tablet form to overcome its relatively low oral bioavailability. In contrast, 7-hydroxymitragynine—the active alkaloid in kratom—occurs in such minute quantities that its overall effect is minimal when consumed in raw plant form, unless it is specifically extracted or synthesized to enhance its potency.

Safety and Side Effects

7-Hydroxymitragynine: As a partial agonist, 7-OH is associated with a reduced risk of respiratory depression and other severe side effects commonly observed with full agonists like morphine. However, chronic use can lead to tolerance, dependence, and withdrawal symptoms .PubMed
Morphine: Known for its high potential for abuse, respiratory depression, and overdose, morphine’s safety profile necessitates careful monitoring during use.

Addiction and Abuse Potential

Morphine: It a Schedule II controlled substance in the U.S., has a well-established high potential for abuse and addiction. Long-term use often leads to tolerance, dependence, and severe withdrawal symptoms, including anxiety, pain, and gastrointestinal distress (DEA).

7-Hydroxymitragynine: (7-OH), a potent kratom alkaloid, is structurally similar to opioids and binds strongly to mu-opioid receptors. Animal studies show it can produce morphine-like effects, including self-administration, indicating potential for abuse (PubMed).

Though found in low concentrations in natural kratom, concentrated extracts pose higher risks. Kratom remains unregulated in many regions, leading to concerns about uncontrolled use and dependency, despite anecdotal reports of it helping some taper off traditional opioids (AP News).

The abuse potential of 7-OH is still under investigation, but its opioid-like activity and availability in potent forms warrant caution.

Benefits of 7-Hydroxymitragynine

7-Hydroxymitragynine, a powerful alkaloid found in the kratom plant, is known for its potent analgesic and mood-enhancing properties. It offers a natural alternative for pain management and emotional well-being when used responsibly.

Natural Origin: Derived from kratom, it is plant-based and often used in its unrefined form.
Lower Risk of Respiratory Depression: Preclinical studies suggest 7-OH has a ceiling effect on respiratory depression—unlike morphine, where overdose can lead to fatal breathing suppression.
Potential for Less Physical Dependence: Some researchers suggest that due to its partial agonist profile, 7-OH might cause less tolerance and dependence than full opioids like morphine.
Multimodal Effects: In addition to pain relief, kratom users often report enhanced mood, mild stimulation, and anxiety reduction—effects not typically seen with morphine.

Risks of 7-Hydroxymitragynine

While 7-Hydroxymitragynine may offer therapeutic benefits, it also carries significant risks, especially with prolonged or high-dose use. Potential side effects include dependency, respiratory issues, and adverse interactions with other substances.

Lack of Regulation: Kratom and its alkaloids are largely unregulated, leading to varying potency and contamination risks.
Addiction Potential: Although possibly lower than morphine, 7-Hydroxymitragynine still binds to opioid receptors and can lead to dependence, tolerance, and withdrawal symptoms.
Insufficient Human Data: Most knowledge comes from animal studies or user reports. Clinical trials on 7-OH are still scarce.
Legal Issues: Kratom and its alkaloids are banned or restricted in several countries and U.S. states.

Benefits of Morphine

Clinically Proven: Morphine is FDA-approved, well-studied, and has been widely used in hospitals for over a century.
Precise Dosing: Medical formulations allow for accurate dosing, which is critical in managing severe or chronic pain.
Rapid Onset: Provides fast relief, especially in acute care or palliative situations.

Risks of Morphine

High Risk of Addiction: As a full opioid agonist, morphine has a high potential for misuse, dependence, and addiction.
Respiratory Depression: Morphine overdose is a leading cause of fatal respiratory failure in opioid-related deaths.
Tolerance and Withdrawal: Users often require escalating doses to achieve the same effect and may experience severe withdrawal symptoms upon cessation.

Key Differences at a Glance

Want a quick breakdown of how 7-hydroxymitragynine stacks up against morphine?
Here’s a side-by-side comparison to highlight their most important differences.

Feature	7-Hydroxymitragynine	Morphine
Source	Kratom plant	Opium poppy
Receptor Activity	Partial mu-opioid agonist	Full mu-opioid agonist
Potency (Analgesic)	~10x more potent than morphine	Baseline opioid
Addiction Risk	Moderate	High
Respiratory Depression	Lower (ceiling effect)	High risk
Legal Status	Varies by region	Prescription only
Human Studies	Limited	Extensive

While both substances interact with opioid receptors, their profiles differ in terms of potency, safety, and legality.Choosing between them requires careful consideration of context, medical guidance, and current regulations.

Legal and Regulatory Considerations

Morphine is classified as a Schedule II controlled substance under the U.S. Controlled Substances Act, meaning it has recognized medical use but a high potential for abuse and dependence (DEA).

7-Hydroxymitragynine (7-OH) is not scheduled at the federal level in the United States. However, because it is a potent opioid receptor agonist and a key active compound in kratom, it is under increasing regulatory scrutiny.

The FDA has issued multiple warnings about kratom’s safety, citing risks of addiction, abuse, and contamination (FDA Statement).
The DEA considered scheduling kratom and its alkaloids (including 7-OH) in 2016 but paused the effort after public and Congressional backlash.
State laws vary: Kratom is banned in several states (e.g., Alabama, Indiana, Wisconsin) and regulated in others (e.g., Utah, Georgia) under Kratom Consumer Protection Acts (American Kratom Association).

Synthetic or concentrated forms of 7-OH are more likely to be targeted by regulatory agencies, especially if marketed as supplements or unapproved drugs. The sale of high-potency extracts may trigger enforcement under the Federal Food, Drug, and Cosmetic Act.

Curious About 7-Hydroxymitragynine? Check Out These Products

From enhanced focus to pain relief, these 7-hydroxy products offer a glimpse into the compound’s powerful potential—here are a few worth checking out.

STACK’D Pure 7-Hydroxymitragynine Tablets 5ct

Discover a new level of potency with STACK’D Pure 7-Hydroxymitragynine Tablets 5ct — a premium solution for experienced kratom users seeking fast, effective relief. Each tablet delivers 18mg of pure, instant-release 7-hydroxymitragynine (7-OH), split into two convenient 9mg servings, for flexible, controlled use.

🌿 Key Features:

High Potency: Each tablet packs 18mg of pure 7-OH — one of the most powerful kratom alkaloids.
Fast-Acting Formula: Instant-release tablets for rapid onset of effects.
Flavor Options: Choose from two refreshing tastes:
- Mint – Cool, crisp, and invigorating.
- Berry – Bold, fruity, and slightly tart.

💊 Product Details:

Format: 5-tablet blister pack (18mg per tablet)
Available Sizes: Choose a 4-pack or stock up with a full case of 12.
Sublingual-Friendly: Designed for under-the-tongue use to bypass digestion and speed up absorption.
Optimized Usage: Best taken on an empty stomach for enhanced effect. Users may boost potency further with potentiators like turmeric or Tums.

🧪 Quality You Can Trust:

STACK’D is proudly crafted by Voodoo Labs, known for their excellence in hemp-derived wellness products and advanced botanical extracts. These tablets are made from fully mature mitragyna speciosa leaves, extracted with precision to ensure maximum alkaloid purity and potency.

GMP-Certified Production
Third-Party Lab Tested for Purity & Safety
Lab-Verified 7-OH Content

🔒 Discreet & Convenient:

Each dose is sealed in a neat blister pack, offering easy portability, discreet use, and accurate dosing — whether you’re at home or on the go.

OPiA 7-Hydroxymitragynine Chewable Tablets 4ct

Get fast, effective kratom support with OPiA 7-Hydroxymitragynine Chewable Tablets 4ct — a flavorful and powerful alternative for those seeking potent, on-the-go relief. Each tamper-proof blister pack contains four chewable tablets, each delivering 20mg of high-purity 7-hydroxymitragynine (7-OH), split into two easily dosed 10mg servings.

🍬 Flavor Meets Function:

Enjoy a flavorful twist on kratom with a chewable format that’s as enjoyable as it is effective. Choose from three bold and refreshing flavor profiles:

Classic – Smooth and familiar with a subtle herbal finish
Blue Raspberry – Sweet, tangy, and packed with berry punch
Mintopia – Cool, crisp mint with a refreshing aftertaste

💪 Potency & Performance:

20mg of 7-OH per tablet (two 10mg servings) for quick, consistent relief
Fast-acting and effective, ideal for boosting natural energy, focus, and overall well-being
Scored tablets allow precise, customizable dosing

While not the strongest extract on the market, OPiA emphasizes purity, consistency, and clean results — making it a reliable daily companion for experienced kratom users and a manageable entry point for newcomers.

🌱 Clean Craftsmanship:

Crafted using fully mature Mitragyna speciosa leaves and all-natural ingredients, these tablets are free from artificial additives and binders. The result is a clean, effective experience you can trust.

GMP Certified Manufacturing
Third-Party Lab Tested (lab results coming soon)
Tamper-Proof Blister Packaging for safety and portability

📦 Convenience Wherever You Go:

Whether you’re at home, at work, or on the move, OPiA Chewable Tablets offer a discreet, flavorful, and effective way to manage your kratom experience. Available in:

Single 4-count blister packs
Full boxes of 10 blister packs for bulk savings and daily reliability

OPiA 7-Hydroxymitragynine Tablets combine powerful relief with crave-worthy flavors, offering a kratom experience that fits your lifestyle. Whether you’re seasoned or starting out, OPiA makes precision and pleasure part of your wellness routine.

Should You Choose 7-Hydroxymitragynine Over Morphine?

The decision isn’t straightforward. While 7-OH may offer a safer, plant-derived alternative with potentially less risk of respiratory depression, it lacks the rigorous clinical oversight and quality control that morphine benefits from.

If you’re managing severe pain under medical supervision, morphine remains the standard. However, for those seeking natural alternatives or suffering from chronic pain, compounds like 7-hydroxymitragynine may warrant further investigation—ideally under the guidance of a healthcare provider.

Final Thoughts So, What’s Stronger?

In terms of pure receptor activity and analgesic potency, the research suggests that:

7-Hydroxymitragynine is stronger than morphine.

But the context matters. If you’re using pharmaceutical morphine vs. raw kratom powder, morphine will generally produce a stronger and more immediate effect due to the tiny amount of 7-hydroxymitragynine in unprocessed kratom.

However, in concentrated or synthetic forms, 7-hydroxymitragynine can outpace morphine—but it also comes with its own risks, especially in unregulated environments.

Conclusion

7-Hydroxymitragynine and morphine both target opioid receptors to alleviate pain, but their profiles are distinctly different. 7-OH stands out for its high potency, plant origin, and lower risk of respiratory depression, while morphine shines in clinical reliability and fast, predictable relief. As the opioid crisis continues, research into alternatives like 7-hydroxymitragynine could offer new hope for safer pain management.

Disclaimer: This blog post is for informational purposes only and is not a substitute for professional medical advice. Always consult your healthcare provider before starting or stopping any medication or supplement.